Cybersecurity-focused AI solutions firm Marknum Technology has secured over 100 million yuan ($14 million) in its Series B round of financing led by Aurora Private Equity and GSR Ventures. In a separate development, medical robots developer HGZ Medical has garnered nearly 100 million yuan ($14 million) Series B round funding led by SDIC.
AI solutions provider Marknum nets over $14m in Series B round
Cybersecurity-focused AI solutions developer Marknum Technology said it has secured over 100 million yuan ($14 million) in its Series B round of financing led by Aurora Private Equity and Chinese global investment company GSR Ventures.
Other investors who participated in the fresh round include Qingdao Wei’er Asset Management and its holding company Zhuhai Wei’er Capital.
Marknum claims to have served the Department of Public Security of Guangdong Province and Zhejiang Province. In addition, it also has a strategic partnership with China Mobile in the area of smart city projects.
Beijing-based Marknum, which has its R&D centre in Nanjing, has partnered public security bureaus, scientific laboratories, and enterprises. It has expanded its presence to cover 30 regions in the country.
The funding proceeds will be allocated to develop AI technologies and extend marketing networks.
Its previous investors include SZ-listed business data service provider Winner Technology, Hongem Investment, Gobi-Hitech Investment, among others.
State-owned SDIC backs medical robots developer HGZ
Beijing-headquartered medical robots developer HGZ Medical on Thursday announced the completion of nearly 100 million yuan ($14 million) Series B round funding led by state-owned SDIC with the participation of Lenovo Capital.
The fresh round comes roughly a year after it secured ‘millions of US dollars’ in its Series A funding from Tong Sheng Capital in March 2019.
HGZ will use the proceeds to advance platform innovation, accelerate R&D of its novel pipelines, and to expand its business.
Established in 2000, HGZ specialises in developing neurosurgery procedure-based medical robots. It said a line of proprietary robots has assisted in about 100,000 surgeries.
HGZ has served over 100 hospitals in China as of 2019 including The General Hospital of the People’s Liberation Army, Xuanwu Hospital Capital Medical University, and Beijing Puhua International Hospital. In February 2019, HGZ’s flagship robot CAS-R-2 achieved incisional biopsy exercise in Huashan Hospital of Fudan University, per its press release.
Launched by the Ministry of Finance and National Development and Reform Commission, SDIC primarily invests in the new economy industries such as information technology, biotechnology, and clean energy.